The Innate Immune Response and Enteric Nervous System in Crohn's Disease.

NCT06485193 — Terminated, 12 participants, Aalborg University Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Det medfødte Immunforsvar og Det Enteriske Nervesystem Ved Crohns Sygdom

RegistryNCT06485193
StatusTerminated - Preliminary results showed no signs of associations in the data.
Study typeObservational
Enrollment12 (Actual)
SponsorAalborg University Hospital (Other)
ConditionsCrohn Disease
InterventionsImmunohistochemistry (Diagnostic test)
Datesstart 2023-09-04, primary completion 2024-06-01, completion 2024-06-01, first posted 2024-07-03, last updated 2024-07-03
Locations1 site in Denmark

Related Papers Related Patents Related Grants Related Experts
All trials for Crohn Disease All trials of Immunohistochemistry

-Summary

The study aims to explore the relationships between inflammation, nerve changes, and the expression of interferon-stimulated proteins in inflamed and non-inflamed bowel areas from patients with Crohn's disease. Crohn's disease is a chronic inflammatory condition with complex causes and mechanisms that remain uncertain despite extensive research.

Methods and Procedures This exploratory study utilizes tissue samples from a clinical biobank at Aalborg University Hospital. The samples are paraffin-embedded blocks from which tissue sections are prepared for immunohistochemical and histological staining. The study focuses on assessing the expression of interferon-stimulated proteins through optimized immunohistochemical staining methods, ensuring reproducibility via automated machines. The protein expressions are then analyzed qualitatively and semi-quantitatively and compared with structural changes in the bowel tissues.

Expand all sections  ·  Collapse all

+Arms and interventions

  • Immunohistochemistry (Diagnostic test): Immunohistochemical analysis of archived diagnostic tissue samples.

+Outcome measures

Primary outcomes

  • MxA expression [June 1 2024]: Immunohistochemical Mxa expression

Secondary outcomes

  • Enterovirus positivity [June 1 2024]: pan-enterovirus immunohistochemistry

+Eligibility

Sex: All

Inclusion Criteria:

* Histological preparations (tissue samples) from patients with Crohn's disease who have undergone bowel resection at Aalborg University Hospital in the period from 2012 to 2023.

Exclusion Criteria:

* If the tissue material does not include the ileocecal region.
* If the pathology report does not indicate that there is tissue material from both inflamed and non-inflamed areas.
* If the patient has registered a prohibition against research in the Tissue Utilization Registry.
* The selection of cases starts with the most recent (by date) and stops when 25 suitable cases are found.

+Locations (1)

FacilityCityCountryStatus
Aalborg University HospitalAalborg, Northern RegionDenmark